US 11,992,699 B2
Internal ultraviolet therapy
Ali Rezaie, West Hollywood, CA (US); Mark Pimentel, Los Angeles, CA (US); Gil Y. Melmed, Los Angeles, CA (US); Ruchi Mathur, Los Angeles, CA (US); and Gabriela Guimaraes Sousa Leite, Porter Ranch, CA (US)
Assigned to Cedars-Sinai Medical Center, Los Angeles, CA (US)
Filed by CEDARS-SINAI MEDICAL CENTER, Los Angeles, CA (US)
Filed on Mar. 14, 2022, as Appl. No. 17/693,855.
Application 17/693,855 is a continuation of application No. 17/507,343, filed on Oct. 21, 2021, granted, now 11,318,325.
Application 17/507,343 is a continuation of application No. 16/992,893, filed on Aug. 13, 2020, granted, now 11,179,575, issued on Nov. 23, 2021.
Claims priority of provisional application 63/012,727, filed on Apr. 20, 2020.
Claims priority of provisional application 62/915,448, filed on Oct. 15, 2019.
Prior Publication US 2023/0035292 A1, Feb. 2, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 5/06 (2006.01)
CPC A61N 5/0624 (2013.01) [A61N 5/0603 (2013.01); A61N 2005/0604 (2013.01); A61N 2005/0651 (2013.01); A61N 2005/0661 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A system for performing intra-corporeal ultraviolet therapy on a subject, the system comprising:
a delivery tube adapted to be positioned inside an intra-corporeal cavity of a subject, wherein the intra-corporeal cavity is a rectum, vagina, urethra, urinary tract, bladder, sigmoid, colon, anus, mouth, esophagus, gastroesophageal junction, stomach, intestines, or biliary tract; and
at least one ultraviolet (UV) light source connected to the delivery tube positioned to deliver UV light outward from the delivery tube, wherein the at least one UV light source is configured to emit the UV light at wavelengths between 335 nm and 349 nm;
wherein a temperature of the delivery tube does not exceed 40° C.; and
wherein the at least one ultraviolet (UV) light source is a light emitting diode (LED) or a string of LED light sources.